共 169 条
[1]
Terstappen GC(2021)Strategies for delivering therapeutics across the blood-brain barrier Nat Rev Drug Discov 20 362-383
[2]
Meyer AH(2022)A historical review of brain drug delivery Pharmaceutics 14 1283-4775
[3]
Bell RD(1991)Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier Proc Natl Acad Sci USA 88 4771-70
[4]
Zhang W(1991)Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo J Pharmacol Exp Ther 259 66-1179
[5]
Pardridge WM(2018)Iron transport kinetics through blood-brain barrier endothelial cells Biochim Biophys Acta Gen Subj 1862 1168-1374
[6]
Friden PM(2018)A blood-brain-barrier-penetrating anti-human transferrin receptor antibody fusion protein for neuronopathic mucopolysaccharidosis II Mol Ther 26 1366-679
[7]
Walus LR(2021)A Phase 2/3 Trial of Pabinafusp Alfa, IDS fused with anti-human transferrin receptor antibody, targeting neurodegeneration in MPS-II Mol Ther 29 671-1277
[8]
Musso GF(2017)Brain and organ uptake in the rhesus monkey in vivo of recombinant iduronidase compared to an insulin receptor antibody-iduronidase fusion protein Mol Pharm 14 1271-82
[9]
Taylor MA(2018)Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1–2 trial Orphanet J Rare Dis 13 110-882.e15
[10]
Malfroy B(2022)Brain delivery of IGF1R5, a single-domain antibody targeting insulin-like growth factor-1 receptor Pharmaceutics 14 1452-242